2,3A-DI-EPI-PERINDOPRIL, (±)-

Details

Stereochemistry	RACEMIC
Molecular Formula	C19H32N2O5
Molecular Weight	368.4678
Optical Activity	( + / - )
Defined Stereocenters	5 / 5
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of 2,3A-DI-EPI-PERINDOPRIL, (±)-

Structure Search

SMILES

CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@@H]1C(O)=O)C(=O)OCC

InChI

InChIKey=IPVQLZZIHOAWMC-XFIYOXNOSA-N

InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14-,15-,16+/m0/s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697

(±)-2,3A-di-epi-Perindopril is a mixture of two isomers (S, SR, RR) and (R, RS, SS) which are both inactive epimers of the antihypertensive drug perindopril, although the (R, RS, SS) isomer possesses better activity.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Angiotensin-converting enzyme 94 Target ID: CHEMBL1808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697	Inhibitor 8504

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Name

Type

Language

(2SR,3ASR,7ARS)-1-((2RS)-2-(((1RS)-1-(ETHOXYCARBONYL)BUTYL)AMINO)PROPANOYL)OCTAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID

Preferred Name

English

2,3A-DI-EPI-PERINDOPRIL, (±)-

Common Name

English

PERINDOPRIL TERT-BUTYLAMINE IMPURITY V [EP IMPURITY]

Common Name

English

(±)-2,3A-DI-EPI-PERINDOPRIL

Common Name

English

Code System Code Type Description

FDA UNII

GR5K6963H1

Created by admin on Mon Mar 31 23:24:00 GMT 2025 , Edited by admin on Mon Mar 31 23:24:00 GMT 2025

PRIMARY

SUBSTANCE RECORD


					GR5K6963H1

2,3A-DI-EPI-PERINDOPRIL, (±)-

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697

Approval Year

Targets

Conditions

Sample Use Guides

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697